Pular para o conteúdo principal
Ranking Invest

AZN - AstraZeneca PLC

Segmento: HealthcareAstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Análise Ranking Invest

Valor de Mercado
$ 269.61 Bi
IVR
0.20Índice proprietário de comparação relativa: 0,20.
IVR2
0.06Leitura proprietária complementar: 6%.
MLL
0.06Leitura proprietária complementar: 6%.
Último Balanço Atualizado: 1T2025

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 40.95 Bi

Dívida Líquida

$ 26.06 Bi

L4T

$ 7.77 Bi

MM4T

14.24%

Indicadores Básicos

ROE

18.98%

Índices de Previsibilidade

Receita Líquida

C0.05

Lucro

F3.02

Margem

F3.66

Índices de Tendência

Receita Líquida

B10.32

Lucro

A9.23

Margem

A8.09

Índices de Endividamento

DIV/PAT

0.64

DIV/L4T

3.35

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.